Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 29.07% is 312% above its 5-year average of -13.69%, near the high end of its 5-year range (-211.91%–55.71%).
As of the fiscal period ended Sunday, June 28, 2026. 18.07% below its 12-month average of 35.48%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-28): 29.07%.
RETURN ON EQUITY (ROE)
29.07%
RETURN ON EQUITY (ROE) AVG TTM
35.48%
RETURN ON EQUITY (ROE) AVG 3Y
-9.58%
RETURN ON EQUITY (ROE) AVG 5Y
-13.69%
RETURN ON EQUITY (ROE) AVG 10Y
3.41%
RETURN ON EQUITY (ROE) AVG 15Y
17.74%
RETURN ON EQUITY (ROE) AVG 20Y
15.39%
CURRENT VS TTM AVG
-18.07%
CURRENT VS 3Y AVG
+403.40%
CURRENT VS 5Y AVG
+312.38%
CURRENT VS 10Y AVG
+751.32%
CURRENT VS 15Y AVG
+63.82%
CURRENT VS 20Y AVG
+88.84%
SECTOR MEDIAN · HEALTHCARE
11.44%
median of 92 covered companies
CURRENT VS SECTOR MEDIAN
+154.11%
vs the sector median at left
Illumina, Inc.
Market Cap
$41.31B
Return on Equity (ROE)
29.07%
TTM Avg
35.48%
3Y Avg
-9.58%
5Y Avg
-13.69%
Market Cap
$40.89B
Return on Equity (ROE)
70.67%
TTM Avg
60.82%
3Y Avg
72.53%
5Y Avg
81.69%
Market Cap
$41.75B
Return on Equity (ROE)
1.09%
TTM Avg
29.98%
3Y Avg
64.02%
5Y Avg
111.55%
Market Cap
$42.50B
Return on Equity (ROE)
22.28%
TTM Avg
21.77%
3Y Avg
21.17%
5Y Avg
17.55%
Market Cap
$46.04B
Return on Equity (ROE)
9.10%
TTM Avg
-6.34%
3Y Avg
-12.86%
5Y Avg
-14.53%
Market Cap
$46.63B
Return on Equity (ROE)
6.65%
TTM Avg
7.05%
3Y Avg
11.93%
5Y Avg
15.09%
Market Cap
$47.38B
Return on Equity (ROE)
19.56%
TTM Avg
20.59%
3Y Avg
21.51%
5Y Avg
20.54%
Market Cap
$48.72B
Return on Equity (ROE)
3.85%
TTM Avg
6.60%
3Y Avg
6.50%
5Y Avg
6.42%
Market Cap
$49.03B
Return on Equity (ROE)
9.46%
TTM Avg
26.07%
3Y Avg
24.86%
5Y Avg
23.86%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Illumina, Inc. (ILMN) | $41.31B | 29.07% | 35.48% | -9.58% | -13.69% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $40.89B | 70.67% | 60.82% | 72.53% | 81.69% |
| Waters Corporation (WAT)vs › | $41.75B | 1.09% | 29.98% | 64.02% | 111.55% |
| IQVIA Holdings Inc. (IQV)vs › | $42.50B | 22.28% | 21.77% | 21.17% | 17.55% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $46.04B | 9.10% | -6.34% | -12.86% | -14.53% |
| Humana Inc. (HUM)vs › | $46.63B | 6.65% | 7.05% | 11.93% | 15.09% |
| Agilent Technologies, Inc. (A)vs › | $47.38B | 19.56% | 20.59% | 21.51% | 20.54% |
| Becton, Dickinson and Company (BDX)vs › | $48.72B | 3.85% | 6.60% | 6.50% | 6.42% |
| Edwards Lifesciences Corporation (EW)vs › | $49.03B | 9.46% | 26.07% | 24.86% | 23.86% |
| Biogen Inc. (BIIB)vs › | $32.49B | 4.43% | 8.42% | 11.86% | 16.52% |
ROE
29.1%
ROA
12.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-28 | 29.07% |
| 2026-03-29 | 31.88% |
| 2025-12-28 | 31.22% |
| 2025-09-28 | 29.53% |
| 2025-06-29 | 55.71% |
| 2025-03-30 | -40.75% |
| 2024-12-29 | -51.50% |
| 2024-09-29 | -74.54% |
| 2024-06-30 | -211.91% |
| 2024-03-31 | -22.48% |
| 2023-12-31 | -20.19% |
| 2023-10-01 | -19.06% |
| 2023-07-02 | -63.86% |
| 2023-04-02 | -67.04% |
| 2022-12-31 | -66.74% |
| 2022-10-02 | -61.70% |
| 2022-07-03 | -0.19% |
| 2022-04-03 | 6.42% |
| 2021-12-31 | 7.09% |
| 2021-10-03 | 8.55% |
| 2021-07-04 | 14.83% |
| 2021-04-04 | 12.80% |
| 2020-12-31 | 13.98% |
| 2020-09-27 | 13.57% |
| 2020-06-28 | 15.19% |
| 2020-03-29 | 20.32% |
| 2019-12-31 | 21.72% |
| 2019-09-29 | 21.92% |
| 2019-06-30 | 21.65% |
| 2019-03-31 | 20.91% |
| 2018-12-31 | 21.48% |
| 2018-09-30 | 19.03% |
| 2018-07-01 | 19.34% |
| 2018-04-01 | 18.45% |
| 2017-12-31 | 25.74% |
| 2017-10-01 | 27.59% |
| 2017-07-02 | 27.76% |
| 2017-04-02 | 29.18% |
| 2016-12-31 | 20.38% |
| 2016-10-02 | 19.11% |
| 2016-07-03 | 20.22% |
| 2016-04-03 | 20.01% |
| 2015-12-31 | 24.97% |
| 2015-09-27 | 26.35% |
| 2015-06-28 | 27.07% |
| 2015-03-29 | 26.49% |
| 2014-12-31 | 24.16% |
| 2014-09-28 | 22.03% |
| 2014-06-29 | 20.23% |
| 2014-03-30 | 13.21% |
| 2013-12-31 | 8.17% |
| 2013-09-29 | 8.48% |
| 2013-06-30 | 8.28% |
| 2013-03-31 | 7.81% |
| 2012-12-31 | 11.47% |
| 2012-09-30 | 7.45% |
| 2012-07-01 | 6.90% |
| 2012-04-01 | 7.64% |
| 2011-12-31 | 8.06% |
| 2011-10-02 | 10.95% |
| 2011-07-03 | 11.01% |
| 2011-04-03 | 12.01% |
| 2010-12-31 | 10.43% |
| 2010-10-03 | 8.86% |
| 2010-07-04 | 7.69% |
| 2010-04-04 | 7.93% |
| 2009-12-31 | 8.36% |
| 2009-09-27 | 8.93% |
| 2009-06-28 | 6.93% |
| 2009-03-29 | 6.53% |
| 2008-12-31 | 5.95% |
| 2008-09-28 | 2.05% |
| 2008-06-29 | 7.99% |
| 2008-03-30 | 7.35% |
| 2007-12-31 | -67.62% |
| 2007-09-30 | -80.05% |
| 2007-07-01 | -89.08% |
| 2007-04-01 | -97.01% |
| 2006-12-31 | 16.16% |
| 2006-10-01 | 10.97% |
| 2006-07-02 | 2.98% |
| 2006-04-02 | -25.08% |
| 2005-12-31 | -28.79% |
| 2005-10-02 | -20.65% |
| 2005-07-03 | -21.75% |
| 2005-04-03 | -0.36% |
| 2004-12-31 | -4.62% |
| 2004-10-03 | -20.70% |
| 2004-06-27 | -25.41% |
| 2004-03-28 | -51.81% |
| 2003-12-31 | -59.50% |
| 2003-09-28 | -62.32% |
| 2003-06-29 | -60.66% |
